# Abscopal Effect of Radiation in Combination With rhGM-CSF for Metastatic Non-small Cell Lung Cancer

> **NCT03113851** · PHASE2 · COMPLETED · sponsor: **Peking University Cancer Hospital & Institute** · enrollment: 40 (actual)

## Conditions studied

- Lung Cancer Metastatic

## Interventions

- **RADIATION:** Radiotherapy
- **DRUG:** rhGM-CSF

## Key facts

- **NCT ID:** NCT03113851
- **Lead sponsor:** Peking University Cancer Hospital & Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-08-14
- **Primary completion:** 2018-08-14
- **Final completion:** 2018-10-14
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2023-06-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03113851

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03113851, "Abscopal Effect of Radiation in Combination With rhGM-CSF for Metastatic Non-small Cell Lung Cancer". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT03113851. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*